Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.90%||63.84||1.0%||$542.01m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.23%||258.59||1.9%||$461.95m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.61%||661.14||2.6%||$422.10m|
|SNSS||Sunesis Pharmaceuticals, Inc.||1.93%||2.11||0.7%||$147.50m|
|EXAS||EXACT Sciences Corp.||-1.54%||53.17||17.7%||$147.09m|
|TXG||10X Genomics, Inc.||0.58%||50.16||0.0%||$101.29m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.56%||79.72||4.2%||$98.40m|
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean GariÃ©py, and Leigh Revers in 2000 and is headquartered in Austin, TX.